Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma

Abstract

We concluded that ESCC patients whose tumors express high levels of Cystatin SN have favourable survival compared with those patients with low Cystatin SN expression. Tumoral Cystatin SN expression may be an independent predictor of survival for patients with resectable ESCCs.